EARNINGS PER SHARE (Tables)

9 Months Ended

Sep. 30, 2026

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Earnings Per Share

The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):


			Three Months Ended September 30,												Nine Months Ended September 30,
			2026						2025						2026						2025
Net Income for Earnings Per Share Calculations:
Income from continuing operations, net of tax			$	301.4					$	292.3					$	923.5					$	991.8
Loss from discontinued operations, net of tax			—						(2.0)						—						(13.6)
Net income			301.4						290.3						923.5						978.2
Less: Net loss attributable to noncontrolling interest			(6.1)						(0.8)						(6.6)						(4.1)
Net income attributable to Edwards Lifesciences Corporation			$	307.5					$	291.1					$	930.1					$	982.3

Weighted Average Shares:
Basic weighted-average shares outstanding			576.3						584.7						577.3						586.2
Dilutive effect of stock plans			1.3						1.0						1.3						1.0
Dilutive weighted-average shares outstanding			577.6						585.7						578.6						587.2
Earnings per Share:
Basic:
Continuing operations			$	0.53					$	0.50					$	1.61					$	1.70
Discontinued operations			—						—						—						(0.02)
Basic earnings per share			$	0.53					$	0.50					$	1.61					$	1.68
Diluted:
Continuing operations			$	0.53					$	0.50					$	1.61					$	1.70
Discontinued operations			—						—						—						(0.03)
Diluted earnings per share			$	0.53					$	0.50					$	1.61					$	1.67